Liver development

  • Aaron M. Zorn,

Division of Developmental Biology, Cincinnati Children's Research Foundation, Cincinnati, Ohio 45229-3039, USA

The liver is the largest internal organ and it provides many essential metabolic, exocrine and endocrine functions. Hepatocytes are the principal cell type in the liver and these along with biliary epithelial cells are derived from the embryonic endoderm. Embryological experiments in animal models have demonstrated that liver development occurs through a progressive series of reciprocal tissue interactions between the embryonic endoderm and nearby mesoderm. In the last ten years many of the genes and molecular pathways that regulate hepatogenesis have been identified. Recently application of this knowledge has enabled researchers to produce “hepatic-like” tissue from embryonic stem (ES) cells in vitro, which may ultimately lead to therapeutically useful tissue for transplantation. This review summarizes the current understanding of the molecular pathways controlling liver and biliary system development focusing on studies in the mouse embryo where this process is best understood.

1. Introduction

The liver is the largest internal organ providing essential metabolic, exocrine and endocrine functions. These include production of bile, metabolism of dietary compounds, detoxification, regulation of glucose levels through glycogen storage and control of blood homeostasis by secretion of clotting factors and serum proteins such as Albumin.

Hepatocytes are the principal cell type in the liver accounting for ∼70% of the mass of the adult organ. Hepatocytes, along with biliary epithelial cells (BECs; also known as cholangyocytes) are derived from the embryonic endoderm, while the stromal cells, stellate cells, kuppfer cells and blood vessels, are of mesodermal origin (see Fig. 1). The use of animal models, such as the mouse, chicken, zebrafish and Xenopus, as well as primary cell cultures has identified many of the genes and molecular pathways regulating embryonic liver development. These studies show that much of hepatogenesis is evolutionarily conserved and occurs through a progressive series of reciprocal tissue interactions between the embryonic endoderms and nearby mesoderm (see Fig. 2; Zaret, 2008; Zhao and Duncan, 2005). The application of this information has recently enabled researchers to produce “hepatic-like” tissue from embryonic stem (ES) cells in vitro, which may ultimately lead to therapeutically useful tissue for transplantation. This review summarizes the current understanding of liver and biliary system development focusing on studies the in mouse embryo where this process is best understood.


Figure 1.
Liver cell lineage.

The cell lineage steps during hepatic development (red) from uncommitted endoderm to functional adult hepatocytes and biliary epithelium.


Figure 2.
Time line of mouse liver development.

The schematic shows mouse embryos at different stages of development with the endoderm tissue highlighted in yellow, the liver in red and the gall bladder in green. The major developmental events are listed below. The endoderm germ layer is formed during gastrulation (e6.5-e7.5). Throughout gastrulation and early somite stages of development (e7-e8.5) the endoderm is patterned along the A-P axis into foregut (fg) midgut (mg) and hindgut (hg) progenitor domains. Morphogenesis forms foregut and hindgut pockets as the endodermal cup is transformed into a gut tube. By e8.5 hepatic fate specified in a portion of the ventral foregut endoderm adjacent to the heart. As the embryo grows the endoderm forms a gut tube and the liver domain moves to the midgut. The liver diverticulum (ld) forms by e9 and expands into an obvious liver bud (lb) by e10. The liver grows, and by e15 hepatoblasts are differentiating into hepatocyte and biliary cells. Final maturation of the liver is gradual and continues into the postnatal period.

1.1. Overview of liver development

The endoderm germ layer is established during gastrulation and forms a primitive gut tube that is subdivided into foregut, midgut and hindgut regions (see Fig. 2). Fate mapping studies in the mouse embryo at embryonic day 8.0 of gestation (e8.0) indicate that the embryonic liver originates from the ventral foregut endoderm (Tremblay and Zaret, 2005). The first morphological sign of the embryonic liver is the formation of the hepatic diverticulum, an out-pocket of thickened ventral foregut epithelium adjacent to the developing heart at e9.0 (see Fig. 2). The anterior portion of the hepatic diverticulum gives rise to the liver and intrahepatic biliary tree, while the posterior portion forms the gall bladder and extrahepatic bile ducts. At e9.5, the hepatic endoderm cells, known as hepatoblasts delaminate from the epithelium and invade the adjacent septum transversum mesenchyme (STM) to form the liver bud (Houssaint, 1980; Le Douarin, 1975; Medlock and Haar, 1983). The STM contributes fibroblasts and stellate cells of the liver. Between e10–15 the liver bud undergoes a period of accelerated growth as it is vascularized and colonized by hematopoietic cells to become the major fetal hematopoietic organ.

The hepatoblasts are bi-potential and those residing next to the portal veins become BECs that will line the lumen of the intrahepatic bile ducts (IHBD), while the majority of hepatoblasts in the parenchyma differentiate into hepatocytes (Lemaigre, 2003; Shiojiri, 1984). The maturation of functional hepatocytes and the formation of a biliary network connected to the extrahepatic bile ducts (EHBD) are gradual. Beginning at e13 this process continues until after birth to generate the characteristic tissue architecture of the liver.

1.2. Cellular architecture of the liver

Within the adult liver, the IHBD, portal vein and hepatic artery run in parallel and are referred to as the “portal triad” (see Fig. 3). The portal triad is surrounded by hepatocytes arranged in single cell sheets known as hepatic plates, separated by sinusoid spaces that are connected to a network of blood vessels capillaries. Blood plasma from the portal vein enters the sinusoid space and comes into direct contact with the basal surface of hepatocytes, which absorb metabolites and toxins. Bile is secreted from the apical surface of adjoining hepatocytes into the bile canaliculi (grooves in the cell surface), and then flows though the IHBD to the extrahepatic bile ducts (EHBD), and into the gall bladder where it is stored before release into the duodenum. This cellular architecture is essential for proper hepatic function.


Figure 3.
Cellular architecture of the liver.

(A) The schematic shows an adult liver (red), with the gall bladder and extra hepatic ducts (green), in relation to the stomach and intestine (yellow). The extra hepatic duct system consists of the hepatic ducts (hd), which drain bile from the liver into the common hepatic duct (chd) to the gall bladder via the cystic duct (cd) and into the duodenum through the common bile duct (cbd). (B) A schematic of the cellular architecture of the liver showing the hepatocytes (pink) arranged in hepatic plates separated by sinusoid spaces radiating around a central vein. Bile canaliculi on the surface of adjoining hepatocytes drain bile into the bile ducts (green), which run parallel to portal veins (blue) and hepatic arteries (red) to form the “portal triad”. (Panel B is adapted with permission from Bloom and Fawcett: A Text Book of Histology 10th Edition).

2. Endoderm formation

In amniotes the definitive endoderm emerges as a sheet of cells from the anterior end of the primitive streak during gastrulation. The multipotent endoderm gives rise to the epithelium of the gastrointestinal and respiratory systems, as well as the glandular and ductal cells of the pancreas, lung, thyroid, thymus and of course the hepatocytes and biliary epithelium. Signaling by the TGFβ growth factor Nodal initiates both endoderm and mesoderm formation in a concentration-dependant manner, with low Nodal doses inducing mesoderm and higher doses inducing endoderm (Shen, 2007; Zorn and Wells, 2007). Nodal signaling stimulates the expression of a core group of endoderm transcription factors including the HMG domain DNA-binding factor Sox17 and the fork head domain proteins Foxa1–3 (HNF3α/β/γ; Zorn and Wells, 2007) which in turn regulate a cascade of genes committing cells to the endoderm lineage.

3. Endoderm patterning: making the foregut

Initial endoderm patterning is coincident with germ layer formation, as the cells that first emerge from the primitive streak give rise to more anterior endoderm (Lawson and Pedersen, 1987). Anterior endoderm fate requires higher levels of nodal signaling than posterior endoderm cells and expresses Foxa2, which is preferentially required to make anterior definitive endoderm (Dufort et al., 1998; Zorn and Wells, 2007).

Throughout gastrulation and the early somite stages of development morphogenetic movements turn the endoderm into an epithelial gut tube surrounded by mesoderm. During this time the gut tube epithelium is further patterned along the anterior-posterior (A-P) axis into foregut, midgut and hindgut domains by secreted factors from the adjacent mesoderm. These domains can be identified by the expression of transcription factors such as Hhex in the foregut, Pdx1 in the midgut and Cdx in the posterior endoderm. (Grapin-Botton, 2005; Moore-Scott et al., 2007). The foregut contains the common precursors of the liver, gall bladder, pancreas and lungs (Chalmers and Slack, 2000; Deutsch et al., 2001; Serls et al., 2005; Tremblay and Zaret, 2005). Initially regional identity is plastic and when posterior mesoderm is experimentally recombined with early foregut endoderm it can repress liver and pancreas development, and the endoderm adopts an intestinal fate (Gualdi et al., 1996; Horb and Slack, 2001; Kumar et al., 2003; Okada, 1954; Wells and Melton, 2000).

3.1. Foregut development requires repression of Wnt/β-catenin and FGF4

Over lapping temporal and spatial gradients of FGF, Wnt, BMP and retinoic acid secreted from the adjacent mesoderm appear to regulate regional identity of the endoderm (Chen et al., 2004; Dessimoz et al., 2006; Kumar et al., 2003; Martin et al., 2005; McLin et al., 2007; Roberts et al., 1995; Stafford et al., 2004; Tiso et al., 2002). Exactly how these pathways confer regional identity is still unresolved, however recent studies in chick and Xenopus support a model where FGF4 and Wnts secreted from the posterior mesoderm repress foregut fate and promote hindgut development, while Wnt and Fgf4 signaling must be inhibited in the anterior endoderm to establish foregut identity (see Fig. 4; Dessimoz et al., 2006; McLin et al., 2007; Wells and Melton, 2000). Secreted Wnt-antagonists expressed in the foregut endoderm, such as Sfrp5 are predicted to keep Wnt signaling off in the foregut region. Experimentally blocking the activity of the canonical Wnt effector β-catenin in the Xenopus posterior endoderm is sufficient to ectopically activate Hhex expression and result in ectopic liver buds in the intestine (McLin et al., 2007). Amazingly only hours later in development Wnt and FGF signaling have the opposite effects and promote hepatic development.


Figure 4.
A model of endoderm patterning by Wnt and FGF.

Recent evidence supports a model where, during gastrulation and early somite stages, differential Wnt and FGF signaling along the A-P axis patterns the naïve endoderm into foregut, midgut and hindgut progenitor domains that express the transcription factors Hhex, Pdx1 and Cdx respectively. While this model remains to be validated genetically in the mouse, the available data suggests that Wnt and FGF ligands expressed in a graded fashion in the mesoderm (red) signal to the adjacent endoderm (yellow) to repress foregut identity and promote hindgut fate. Secreted Wnt-antagonists expressed in the anterior endoderm are predicted to repress canonical Wnt/β-catenin activity.

3.2. Hepatic competence

Establishment of the foregut progenitors is important step in hepatogenesis because in vivo only the foregut endoderm (but not the hindgut) is competent to develop into the liver (Fukuda-Taira, 1981; Le Douarin, 1975; Okada, 1954; Okada, 1960; Takata, 1960). This intrinsic hepatic potential is probably due to the expression of transcription factors such as Foxa2, Gata4–6 and Hhex, which have important roles in early foregut organogenesis. In vivo DNA-binding studies in the mouse embryonic endoderm suggest that Foxa and Gata factors bind to enhancer elements of the Albumin gene to enhance chromatin accessibility and increase the ability or “competence” of such hepatic genes to be transcribed (Bossard and Zaret, 1998; Bossard and Zaret, 2000; Gualdi et al., 1996). Consistent with this the conditional deletion of both Foxa1 and Foxa2 from the early foregut prevents liver induction (Lee et al., 2005).

4. Hepatic induction by FGF and BMP

At early somite stages of development (e8.5; 4–7 somites stage in mice), FGF signals from the developing heart and BMPs from the STM induce hepatic fate in the ventral foregut endoderm (see Fig. 5; Fukuda-Taira, 1981; Gualdi et al., 1996; Jung et al., 1999; Le Douarin, 1964a; Le Douarin, 1964b; Le Douarin, 1975; Rossi et al., 2001). This has been extensively studied using mouse embryo foregut explants, which when isolated at the 2–4-somite stage will express Albumin after 1–2 days in culture if the cardiac mesoderm is present. However, if the cardiac mesoderm is removed, or if either FGF or BMP signaling is blocked, liver induction does not occur (Calmont et al., 2006; Gualdi et al., 1996; Rossi et al., 2001). Furthermore, exogenous FGF1 or FGF2 can replace the cardiac mesoderm and induce Albumin expression in foregut endoderm explants (Jung et al., 1999). BMP signaling however is required, but not sufficient, for hepatic induction in explants and may act in part by maintaining Gata4/6 expression (Rossi et al., 2001).


Figure 5.
Hepatic induction.

The figure depicts the lateral view of the anterior portion of an e8.25 (2–4 somite stage) mouse embryo (right). The developing head is shown in grey. At this stage the definitive endoderm (yellow) is forming a foregut pocket. The liver (lv) is induced a portion of the ventral foregut by FGF signals from the cardiogenic mesoderm (red) and BMPs from the septum transversum mesenchyme (orange). Foregut endoderm isolated after the 5–7 somite stage will express liver genes such as Albumin, indicating that hepatic fate is specified. Different doses of FGF appear to induce lung (lu) and ventral pancreas (pa) from the foregut progenitors. Signals from the axial mesoderm (candidates included FGF4 and Wnt ligands) repress hepatic fate in the dorsal endoderm.

Analysis of the signal transduction pathways downstream of FGF signaling indicates that the MAP kinase pathway regulates hepatic gene expression whereas the PI3 kinase pathway promotes hepatic growth (Calmont et al., 2006). Gene targeting of FGF and BMP pathway components has not yet revealed a liver-induction phenotype in mice, due to early embryonic lethality and/or functional redundancy. However genetic analysis in zebrafish as well as experiments in chick and Xenopus indicate BMP and FGF signaling cooperatively regulate hepatic liver specification in these species (Chen et al., 2003; Shin et al., 2007; Zhang et al., 2004). In addition, Wnt2bb in the lateral plate mesoderm is required for hepatic specification in zebrafish (Ober et al., 2006). Wnt2 and Wnt2b are also expressed in the mouse lateral plate mesoderm at the time of hepatic induction but their role has yet to be determined.

Mouse explant studies also suggest that different concentrations of FGF are critical for segregating different foregut organ lineages are from a common progenitor cell population, with high, intermediate and low levels of FGF signaling promoting lung, liver and ventral pancreas respectively (Deutsch et al., 2001; Serls et al., 2005). It is still unclear whether it is the proximity, or the length of time that the endoderm is in contact with the cardiac mesoderm that controls the FGF dose. This process may be regulated in part by the homeobox gene Hhex (see Fig. 6), which regulates the proliferation of foregut endoderm cells and causes the epithelium to move in relation to the FGF-secreting cardiac mesoderm during development (Bort et al., 2004).


Figure 6.
Hhex expression in the ventral foregut endoderm.

A mid-sagittal section of the anterior region of an e8.5 embryo (anterior up, ventral left) shows immunostaining of Hhex protein (green) in the ventral foregut endoderm adjacent to the developing heart (pseudo-colored red). The dapi stained nuclei are blue. Image courtesy of Jason Spence.

5. Liver bud morphogenesis

Shortly after hepatic specification (e8.5 to e9.0) the epithelium begins to express liver genes (Albumin, Afp, Hnf4α) and thickens as the cells transition from a simple cuboidal to a pseudostratified columnar epithelium, thus forming the liver diverticulum (Bort et al., 2006). Between e9.0 to e9.5 the laminin-rich basal layer surrounding the hepatic endoderm breaks down, and the hepatoblasts delaminate and migrate into the STM to form the nascent liver bud (see Fig. 7 and Fig. 8; Bort et al., 2006; Houssaint, 1980; Margagliotti et al., 2008; Medlock and Haar, 1983; Shiojiri and Sugiyama, 2004). Several transcription factors, as well as signals from endothelial cells are required for this process.


Figure 7.
Liver bud morphogenesis.

The schematics depict transverse sections through the gut tube at the level of the liver diverticulum at different developmental stages in liver bud formation. After hepatic specification by FGF and BMP signals from the heart and septum transversum mesenchyme (STM) the hepatoblasts begin to express liver markers, the hepatic epithelium thickens then and transitions from a columnar to a pseudostratified epithelium (e8.75-e9.0). At this stage the hepatic epithelium is embedded in the STM and surrounded by a laminin rich basement membrane and endothelial cell precursors. By e9.5 the basal lamina breaks down and hepatoblasts delaminate and migrate into the STM to form the liver bud. Signals from the endothelial cells, the STM, as well as the activity of the indicated genes are required for this process.


Figure 8.
An example of hepatoblast delamination.

(A) An X-gal stained e9.5 double transgenic Foxa3cre;Rosa26-reporter embryo expresses cre-recombinase in the endoderm (Lee et al., 2005), which activates the Rosa26-reporter allele resulting in permanent β-galactosidase expression in the gut epithelium and liver diverticulum (l.d.). (B) A transverse section through the liver diverticulum of the embryo in (A) stained with anti-HNF4α antibodies, shows the endoderm in blue and the HNF4α-expressing hepatoblasts invading the STM.

5.1. Hhex and Gata

Initially expressed throughout the ventral foregut endoderm, the homeodomain factor Hhex becomes enriched in the hepatic endoderm by e8.5 (see Fig. 6) and then persists in all the hepato-biliary cell lineages throughout development (Bogue et al., 2000; Hunter et al., 2007; Thomas et al., 1998). Hhex-/- embryos lack liver, gall bladder and ventral pancreas buds at e10.5 (Keng et al., 2000; Martinez Barbera et al., 2000) and studies indicate that Hhex function is required at multiple time points in the development of these lineages (Bort et al., 2004; Hunter et al., 2007; sections 4, 7 and 8). In addition to controlling foregut endoderm proliferation, Hhex is required for hepatoblast delamination. In e9.0 Hhex-/- embryos the hepatic endoderm transiently expresses liver genes, but the epithelium arrests in a simple columnar state, the hepatoblasts fail to invade the STM (Bort et al., 2006).

The zinc finger transcription factors Gata4 and Gata6 are expressed in a variety of tissues including the foregut endoderm, heart and STM. Mutations in either Gata4 or Gata6 result in early lethality due to defects in the extra embryonic tissue (Duncan, 2005). However in tetraploid chimeric embryos where only the epiblast was derived from Gata4-/- or Gata6-/- ES cells, hepatic development arrested at ∼e9.5 (Watt et al., 2007; Zhao et al., 2005). Similar to the Hhex mutants, hepatic gene expression was initiated but not maintained and the hepatoblasts failed to delaminate. Gata4-/- embryos also lack STM suggesting that part of the defect could be non-cell autonomous (Watt et al., 2007). Compound Gata4-/-; Gata6-/- mutants have early defects in foregut morphogenesis but the liver phenotype has not yet been reported in these embryos (Zhao et al., 2008). The proposed role for Gata factors in hepatic competence (section 3.2) predicts that liver development should not initiate in the compound mutants, which is consistent with the antisense depletion of Gata4, Gata5 and Gata6 in zebrafish and Xenopus embryos (Afouda et al., 2005; Holtzinger and Evans, 2005; Shin et al., 2007).

5.2. Prox1, Onecut and the ECM

The homeodomain transcription factors Prox1, Onecut-1 (OC-1, also known as Hnf6) and Onecut-2 (OC-2) also regulate hepatoblast delamination, but act slightly later than Hhex and Gata. Prox1 is expressed in the hepatic epithelium by e8.5 (Burke and Oliver, 2002). In Prox1-/- embryos hepatoblasts are specified and begin to proliferate, but the basal lamina fails to degrade and the cells remain trapped in the hepatic diverticulum (Sosa-Pineda et al., 2000). OC-1 and OC-2 are expressed in the foregut endoderm and hepatoblasts, and are redundantly required for the timely degradation of the basal lamina (Margagliotti et al., 2007). At e9.5, OC-1;OC-2 double mutants resemble the Prox1-/- phenotype, but later hepatoblast invasion recovers resulting in a hypoplastic fetal liver. These mutant livers also have bile duct and gall bladder defects due to later roles of OC-1 and OC-2 (sections 7.2 & 8).

Hepatoblasts normally down regulate E-cadherin as they migrate into the STM, however this does not occur properly in Prox1 and OC1;OC2 mutants. Studies suggest that Prox1 and Onecut factors control hepatoblast migration by regulating the expression of extra cellular matrix (ECM) proteins and ECM remodeling enzymes such as matrix metalloproteinases (MMPs; Margagliotti et al., 2007; Medico et al., 2001; Papoutsi et al., 2007). Hepatoblasts and the STM express several MMPs at e9.5 and pharmacological inhibition of MMP activity suppresses hepatoblast migration in culture (Margagliotti et al., 2008). The importance of cell-ECM interactions is also illustrated by the fact that hepatoblasts deficient for the laminin receptor β1-integrin are unable to colonize the liver bud (Fassler and Meyer, 1995). Small GTPases, well known for regulating cell migration, also appear to be involved because hepatoblasts fail to invade the STM in embryos with null mutations in the Pccmt gene, which encodes a GTPase modifying enzyme (Lin et al., 2002).

5.3. Endothelial signals

At e9.0, prior to vascularization of the liver bud, endothelial precursor cells lay between the hepatic epithelium and the STM (see Fig. 7). This close contact with blood vessels persists as hepatoblasts migrate into the stroma. Null mutations in the vascular endothelial growth factor receptor gene Vegfr-2 (also known as Flk-1) results in embryos that lack endothelial cells and the hepatoblasts fail to delaminate in these embryos (Matsumoto et al., 2001). In addition angiogenesis inhibitors repress liver bud growth in culture, suggesting that endothelial cells provide unknown paracrine factors promoting hepatoblast migration and/or proliferation. One candidate that has emerged from chick embryo studies is the Glial-derived neurotrophic factor, Neurturin, which is secreted from blood vessels and acts as a hepatoblast chemoattractant via the GFRα2 receptor (Tatsumi et al., 2007).

6. Liver bud growth

Between e9.5 to e15 the liver bud undergoes tremendous growth and becomes the major site of fetal haematopoiesis. This growth is regulated by paracrine signals from hepatic mesenchyme, as well as by genes that act intrinsically in the hepatoblasts. Mutations in many of these genes result in a similar embryonic lethality between e10-e16 due to impaired hepatoblast proliferation and/or increased cell death, which often causes severe anemia because the defective liver cannot support fetal haematopoiesis.

6.1. Mesenchymal signals

The STM and hepatic mesenchyme (e.g. stellate cells) secrete a variety of growth factors including; FGF, BMP, HGF, Wnt, TGFβ and RA that promote hepatoblast migration, proliferation, and survival (see Fig. 9).


Figure 9.
Liver bud growth.

The schematics depict the liver bud at e9.5 when the hepatoblasts are invading the STM and at e10.5, when the hepatoblasts have grown into the liver bud in characteristic “chords” that are intermingled with the hepatic mesenchyme. At e10.5 haematopoietic cells also colonize the liver bud. Some the genes involved in liver bud growth are indicated.

In addition to their earlier role in hepatic specification, FGF (via PI3 kinase) and BMP signaling also promote liver bud growth (Berg et al., 2007; Calmont et al., 2006; Jung et al., 1999; Rossi et al., 2001; Sekhon et al., 2004; Shin et al., 2007; Yanai et al., 2008). Hepatocyte Growth Factor (HGF) signaling through its tyrosine kinase receptor c-Met (Defrances et al., 1992; Iida et al., 2003; Ishikawa et al., 2001) is also required for hepatoblast proliferation (Birchmeier et al., 2003; Bladt et al., 1995; Moumen et al., 2007; Sachs et al., 2000; Schmidt et al., 1995). In addition to being a hepatocyte mitogen HGF also promotes hepatoblast migration (Block et al., 1996; Medico et al., 2001; Michalopoulos et al., 1993), in part by activating the small GTPase Arf6 (Suzuki et al., 2006).

Although Wnt/β-catenin signaling appears to repress liver fate during earlier endoderm patterning stages of development (section 3.1), by e10 in the liver bud β-catenin has the opposite effect and promotes hepatic growth (McLin et al., 2007; Micsenyi et al., 2004; Monga et al., 2003; Suksaweang et al., 2004; Tan et al., 2008). While the Wnt ligands involved are unclear (Zeng et al., 2007), in the chick Wnt9a is expressed in hepatic fibroblasts, and antisense depletion of Wnt9a inhibits liver bud growth in culture (Matsumoto et al., 2008). Multiple TGFβ ligands are also expressed in the liver bud mesenchyme (Pelton et al., 1991). Embryos with compound heterozygous mutations in the TGFβ transcriptional mediators Smad2 and Smad3 have hypoplastic livers (Weinstein et al., 2001), as do embryos deficient for the Smad interacting protein, Elf5 (Tang et al., 2003) and the receptor TGFβRIII (Stenvers et al., 2003)

Liver bud growth also requires retinoic acid signaling (Wang et al., 2006), which is controlled in part by the zinc finger transcription factor WT1 expressed in the STM and stellate cells (Ijpenberg et al., 2007). The homeobox genes Hlx and Lhx2 as well as N-myc are also expressed in the STM, and null mutations in each of these results in reduced hepatoblast proliferation and increased apoptosis (Giroux and Charron, 1998; Hentsch et al., 1996; Porter et al., 1997; Wandzioch et al., 2004), suggesting that they regulate the production of paracrine signals from the mesenchyme. Exactly how these different transcription factors and signaling pathways coordinate hepatic growth remains to be determined, but extensive cross talk appears to exist (Apte et al., 2006; Rossi et al., 2001; Weinstein et al., 2001). For example, explant cultures suggest that HGF and TGFβ signaling act in parallel converging on β1-integrin regulation (Weinstein et al., 2001). Moreover, FGF and HGF signaling stimulate many of the same intracellular kinase cascades (e.g. MAPK, JNK, Pi3K), and both have been reported to stimulate the activity of β-catenin in the liver bud, suggesting crosstalk with the Wnt pathway (Berg et al., 2007; Monga et al., 2002; Sekhon et al., 2004).

6.2. Hepatoblast proliferation and survival

A number of genes encoding regulators of proliferation, cell survival or metabolic stress are also required for liver bud growth including; c-jun (Eferl et al., 1999; Hilberg et al., 1993), Xbp1 (Reimold et al., 2000), Jumonji (Motoyama et al., 1997), Foxm1b (Krupczak-Hollis et al., 2004), MTF-1 (Gunes et al., 1998), Nrf1 (Chen et al., 2003), Tbx3 (Suzuki et al., 2008) and signal transduction components K-ras (Johnson et al., 1997), Pi3kr1 (Fruman et al., 2000), Raf1 (Mikula et al., 2001) and Sek1 (Ganiatsas et al., 1998; Nishina et al., 1999; Watanabe et al., 2002). Regulation of the inflammatory cytokine Tumor Necrosis Factor alpha (TNFα) is also important and embryos lacking components of the anti-apoptotic NFκβ complex exhibit TNFα mediated hepatoblast apoptosis (Beg et al., 1995; Bonnard et al., 2000; Doi et al., 1999; Li et al., 1999; Rosenfeld et al., 2000).

7. Differentiation of hepatocytes and biliary epithelial cells

The differentiation of bi-potential hepatoblasts into hepatocytes or BECs begins around e13 of mouse development. Initially hepatoblasts express genes associated with both adult hepatocytes (Hnf4α, Albumin) and BECs (cytokeratin-19), as well as fetal liver genes such as α-fetoprotein (Afp). Hepatoblasts in contact with the portal vein form a monolayer, and then a bi-layer, of cuboidal biliary precursors that increase cytokeratin-19 (CK-19) expression and down-regulate hepatic genes. Between e17 and into the perinatal period focal dilations appear in the bi-layer and these become surrounded by portal mesenchyme to form IHBD, while the remaining bi-layer cells regress (see Fig. 10). This process, which involves tubulogenesis and apoptosis, is known as ductal plate remodeling. (Lemaigre, 2003; Sergi et al., 2000). Hepatoblasts in the liver parenchyma that are not in contact with portal veins gradually differentiate into mature hepatocytes. At e17 hepatocytes acquire their characteristic epithelial morphology arranged in hepatic chords with bile canaliculi on the apical surfaces. While defects in early liver bud growth are often embryonic lethal, disruption in hepatocyte maturation/function or ductal plate remodeling malformations (see Fig. 11) are observed in many human disorders (Sergi et al., 2000; Suchy, 2003; Desmet, 2005).


Figure 10.
Bile duct formation.

The schematics show the steps of intrahepatic bile duct formation. Starting at e13 hepatoblasts in contact with the portal vein mesenchyme begin to adopt a biliary epithelium fate and form cuboidal epithelail layer. This layer duplicates and from e17 to the perinatal period, a process known as ductal plate remodeling results in focal dilations in the bi-layer which become surrounded by portal mesenchyme to form bile ducts, while the remaining bi-layer cells regress. Hepatoblasts in the parenchyma differentiate into hepatocytes.


Figure 11.
Histology of normal and defective intrahepatic bile ducts.

Histological staining of human liver sections at: (A) 16 weeks of development showing focal dilations (arrows) in the bi-layer of the biliary epithelial cell precursors surrounding the portal vein (pv). (B) A mature liver showing the bile ducts (bd) and hepatic artery (ha) embedded in the periportal mesenchyme in a characteristic arrangement known as the “portal triad”. Hepatocytes are arranged in chords surround the portal triad. (C) The portal triad region from an Alagille syndrome patient showing ductal cysts rather than normal bile ducts as a result of defects in ductal plate remodeling. Images courtesy of Gail Deutsch.

7.1. Hepatocyte differentiation

During mid-gestation the haematopoietic cells in the liver secrete the cytokine Oncostatin M (OSM), which in combination with glucocorticoid hormones, HGF and Wnt promotes hepatocyte differentiation (Kamiya et al., 2001; Matsui et al., 2002; Michalopoulos et al., 2003; Suzuki et al., 2003; Tan et al., 2008). OSM induces metabolic maturation by activating the gp130 receptor and a JAK/Stat3 signaling pathway (Ito et al., 2000; Kamiya et al., 1999), while promoting morphological maturation into polarized epithelium via K-ras and E-cadherin (Imamura et al., 2007; Matsui et al., 2002). Some evidence suggests that HGF and OSM activity is balanced by TNFα, which inhibits maturation and maintains the proliferative capacity of fetal hepatocytes, allowing the liver to grow to the appropriate size before differentiating (Kamiya and Gonzalez, 2004).

These secreted factors act in part by regulating a number of liver-enriched transcription factors including C/EBPα, HNF1α, Foxa1–3, nuclear hormone receptors and HNF4α (see Fig. 12), which function in a complex inter-regulatory network to control hepatocyte gene expression (Cheng et al., 2006; Kyrmizi et al., 2006; Odom et al., 2004; Qu et al., 2007). Genetic analysis has confirmed a role for HNF4α, C/EBPα and HNF1α in hepatocyte differentiation. HNF4α is first expressed in hepatoblasts at e9.0 and Hnf4α-/- fetal hepatocytes fail to express many mature hepatic enzymes and lack normal hepatocyte morphology (Li et al., 2000; Parviz et al., 2003; Watt et al., 2003). Genome scale chromatin immunoprecipitation assays suggest that HNF4α binds to the promoters of nearly half of the genes expressed in the mouse liver (Odom et al., 2004), including genes encoding cell adhesion and junctional proteins (Battle et al., 2006) important in hepatocyte epithelial structure (Konopka et al., 2007; Satohisa et al., 2005). C/ebpα-/- and Hnf1α-/- mice die neonatally from hypoglycemia caused by impaired hepatocyte maturation and defective glycogen storage (Pontoglio et al., 1996; Wang et al., 1995), similar to mutations in the OSM receptor gp130 (Kamiya et al., 1999). C/EBPα appears to inhibit hepatoblast proliferation and biliary development, while mediating HGF-induced hepatic gene expression (Rastegar et al., 2000; Shiojiri et al., 2004; Soriano et al., 1995; Suzuki et al., 2003; Tomizawa et al., 1998; Yamasaki et al., 2006)


Figure 12.
Hepatocyte and Biliary epithelium lineage segregation.

The schematic illustrates a model of hepatoblast differentiation into hepatocytes or biliary epithelial cells (BEC). Bi-potential hepatoblasts express fetal liver genes (Afp) as well as markers of both hepatocytes (Albumin) and BECs (CK19). Evidence suggests that signals (possibly TGFβ and Wnts) from the periportal mesenchyme enhance the expression of BEC promoting transcription factors (OC1, OC2, HNF1β) in the adjacent hepatoblasts, while at the same time these signals repress the expression of hepatogenic transcription factors (HNF4 and C/EBP). In contrast hepatoblasts in the parenchyma (that do not experience the periportal mesenchyme signals) up regulate the expression of hepatogenic factors. Mutual antagonism between the two groups of transcription factors is thought to reinforce this lineage segregation. Continued signaling (Notch, EGF and HGF) from the periportal mesnechyme are essential for ductal plate remodeling, while other factors (OSM, Dex, HGF and Wnt) promote hepatocyte maturation.


Figure 13.
In vitro hepatic differentiation from ES cells.

The diagram depicts a generalized protocol summarized from the work of several labs that have applied developmental paradigms to mouse and human ES cells to direct the differentiation of hepatic-like cell in vitro. The factors added to the cultures, the durations of exposure, and the developmental step that these treatments are meant to mimic are indicated below. The cell types and key lineage specific marker genes expressed in those cells are indicated.

7.2. Biliary epithelial cells

TGFβ, Wnt and Notch are candidate signals from periportal mesenchyme that promotes BEC development (see Fig. 12). There is evidence that a TGFβ signaling gradient emanating from the portal region promotes biliary differentiation in the adjacent hepatoblasts (Clotman et al., 2005; Clotman and Lemaigre, 2006; Weinstein et al., 2001). Wnt/β-catenin signaling also promotes BEC development (Decaens et al., 2008; Hussain et al., 2004; Monga et al., 2003; Tan et al., 2008), and may act in part by stimulating the expression of EGF, which along with HGF can induce the formation of biliary structures in cultured hepatocytes (Block et al., 1996; Michalopoulos et al., 2003; Tan et al., 2005).

Human Alagille syndrome (OMIN #118450) patients with autosomal dominant mutations in the Notch ligand gene Jagged-1 (Li et al., 1997; Oda et al., 1997; Yuan et al., 2006) have a paucity of IHBD (see Fig. 11), as do mice with compound heterozygous Jagged-1; Notch-2 mutations (McCright et al., 2002). Recent analyses suggest that Jagged-1 expressed in the portal mesenchyme activates Notch-2 in adjacent hepatoblast, and this is required to maintain (but not initiate) BEC differentiation and for proper bile duct morphogenesis (Kodama et al., 2004; Loomes et al., 2007; Lozier et al., 2008; Tanimizu and Miyajima, 2004).

In response to the mesenchyme signals the periportal hepatoblasts down regulate pro-hepatic factors HNF4α, Tbx3 and C/EBP (which repress BEC development) and increase expression of BEC transcription factors OC1/HNF6, OC2 and HNF1β (see Fig. 12; Rastegar et al., 2000; Shiojiri et al., 2004; Suzuki et al., 2008; Tanimizu and Miyajima, 2004; Yamasaki et al., 2006). Fetal livers deficient for OC1/HNF6, OC2, HNF1β or Hhex exhibit excessive biliary cysts that fail to form proper IHBDs (Clotman et al., 2005; Clotman et al., 2002; Coffinier et al., 2002; Hunter et al., 2007). At e13-e15 Hhex, OC1 and OC2 appear to regulate early hepato-biliary lineage segregation and attenuate premature BEC differentiation. OC1 and OC2 may act in part by modulating the response of hepatoblasts to TGFβ signaling (Clotman et al., 2005). Later in development Hhex and OC1 function upstream of HNF1β and are required for ductal plate remodeling (Clotman et al., 2002; Coffinier et al., 2002; Hunter et al., 2007; Matthews et al., 2004).

In addition to reduced hepatoblast proliferation Foxm1b-/- fetal livers lack IHBDs (Krupczak-Hollis et al., 2004). It is currently unclear how Foxm1b fits into the genetic pathway of BEC development. Interestingly cell lines have been derived from bipotential fetal hepatoblasts that can be maintained and differentiated in vitro (Rogler, 1997; Strick-Marchand and Weiss, 2002). These are likely to be instrumental in dissecting the genetic cascades regulating BEC/hepatocyte lineage segregation as well as provide potential source of hepatic tissue for tissue replacement therapy (section 9; Ader et al., 2006; Strick-Marchand et al., 2004; Strick-Marchand and Weiss, 2003).

8. Gall bladder and extrahepatic bile ducts

Although BECs line the lumen of both the intrahepatic and extrahepatic biliary tract they have distinct developmental origins (Roskams and Desmet, 2008), with the BECs of the gall bladder and extrahepatic bile ducts (EHBD) arising from the caudal portion of the hepatic diverticulum. While some of the same genes control BEC fate in both the IHBD and EHBD, other aspects of their development appears distinct. For example HNF6, HNF1b, Hhex and the Notch signaling effector Hex1 are required for IHBD as well as for gall bladder and EHBD development (Clotman et al., 2002; Coffinier et al., 2002; Hunter et al., 2007). However haploinsufficency of the transcription factor Foxf1 results in a lack of EHBDs and a small gall bladder, but IHBDs are unaffected (Kalinichenko et al., 2002). Foxf1 is expressed in the STM suggesting that it acts indirectly on the hepato-biliary epithelium. Evidence for such an extra-cellular signal has come from zebrafish where Fgf10 in the lateral plate mesoderm regulates the boundary between the liver, gall bladder, ventral pancreas and EHBD (Dong et al., 2007).

9. Liver stem cells

The adult liver has a remarkable regenerative capacity and can completely re-grow when up to 70% of its mass is removed (Fausto et al., 2006; Michalopoulos, 2007). However this ability is impaired in numerous diseases such as advanced cirrhosis and hepatitis resulting life threatening liver failure for which organ transplantation is currently the only clinical option. The implantation of isolated hepatocytes or the use of bio-artificial liver devices to provide limited liver function, are also becoming potential options (Dan and Yeoh, 2008; Horslen and Fox, 2004; McKenzie et al., 2008). However, the scarcity of organ donors and the difficulty in culturing adult hepatocytes are serious limitation to this approach. Hepatic tissue made from stem cells holds the promise of an unlimited source of material for transplantation. Moreover the availability of large quantities of human hepatic tissue would facilitate the design of new pharmaceuticals as testing for liver toxicity is a common step in drug development. Researchers have attempted to generate hepatocytes from a variety of adult, fetal and embryonic stem cell sources (Dan and Yeoh, 2008; Lavon and Benvenisty, 2005; Oertel and Shafritz, 2008). These efforts, particularly the recent successes with embryonic stem (ES) cells, have been greatly facilitated by our understanding of embryonic liver development.

9.1. Regeneration and adult hepatic stem cells

The liver regenerates primarily by the proliferation of mature hepatocytes (Fausto et al., 2006; Michalopoulos, 2007). However, the adult liver also contains hepatic progenitor cells that are activated when hepatocyte proliferation is inhibited, such as in severe cirrhosis (Fausto, 2004; Oertel and Shafritz, 2008). The hepatic progenitors appear to reside in the small terminal bile ducts and when activated they proliferate giving rise to a cell population called “oval cells”, which can differentiate into both hepatocytes and BECs (Fougere-Deschatrette et al., 2006; Oertel and Shafritz, 2008). The bipotential nature of oval cells suggests that they originate from fetal hepatoblasts that remain undifferentiated in a stem cell niche within the ducts (Schmelzer et al., 2006). Rodent Oval cell lines have been generated (Fougere-Deschatrette et al., 2006; Oertel and Shafritz, 2008) and provide useful experimental models, but the exact origin and characteristics of hepatic progenitors in vivo are still obscure (Dan and Yeoh, 2008; Jelnes et al., 2007; Ochsner et al., 2007; Oertel et al., 2008; Yovchev et al., 2008). Interestingly, many of the developmental pathways that regulate hepatogenesis in the embryo, such as HGF, FGF, OSM, TNFα and Wnt appear to control Oval cell activation (Apte et al., 2008; Bird et al., 2008; Hu et al., 2007) as well as hepatocyte proliferation during regeneration. (Fausto, 2004; Kelley-Loughnane et al., 2002; Michalopoulos, 2007; Tan et al., 2006).

9.2. Making liver from ES cells

ES cells are capable of unlimited self-renewal and can differentiate into any cell type in the adult. For years investigators attempted to promote hepatic differentiation in ES cells, however initial results were hampered by variability, low yields and the heterogeneous nature of the cultures (Lavon and Benvenisty, 2005). The breakthrough came from recapitulating the pathways controlling normal hepatic development in ES cells.

The critical first step was the demonstration that mouse and human ES cell could efficiently generate definitive endoderm (DE) tissue (∼80% of the cells) by treating the cultures with high concentrations of the TGFβ family ligand Activin, to mimic the role of Nodal in the gastrula embryo (D’Amour et al., 2005; Kubo et al., 2004; Yasunaga et al., 2005). Remarkably Activin treated ES cells express mesendoderm genes in a temporal fashion nearly identical to mammalian gastrulation. After a few days most of the cells express definitive endoderm genes (Sox17 and Foxa2), while mesoderm, pluripotency (e.g. Oct4) and extra embryonic endoderm genes are down regulated (D’Amour et al., 2005; Kubo et al., 2004). Using this DE tissue as a starting material, a number of groups have generated hepatic-like cells from mouse and human ES cells in culture (reviewed in Dan and Yeoh, 2008; Oertel and Shafritz, 2008). While the details of the 15–20 day long differentiation protocols vary, most involve plating the DE on matrix (e.g. collagen) to mimic the hepatic ECM and then added FGF and/or BMP to mimic hepatic induction. This is followed by some combination of HGF, OSM, FGF and Dexamethasone to expand the hepatoblast population and to promote hepatic maturation (Agarwal et al., 2008; Baharvand et al., 2007; Cai et al., 2007; Chen et al., 2006; Cho et al., 2008; Gouon-Evans et al., 2006; Hay et al., 2008; Soto-Gutierrez et al., 2007; Teratani et al., 2005). A detailed understanding of the stage specific genes expressed during normal liver development has allowed researchers to monitor the progress of hepatic differentiation in vitro.

Using these developemental protocols on mouse and human ES cells, researchers have successfully generated cultures where up to 70% of the cells exhibit a “hepatocyte-like” phenotype. These cells exhibit many features of hepatocytes including; (1) expression of hepatic enzymes, (2) hepatocyte morphology, (3) robust glycogen storage, (4) uptake and metabolizism of drugs and (5) secretion of albumin. Finally several groups have found that transfusion of ES derived hepatocytes into mice with various liver injury models exhibited a modest rescue of liver function, although engraftment of the cells into the host liver was very low (Agarwal et al., 2008; Cai et al., 2007; Gouon-Evans et al., 2006; Heo et al., 2006; Sharma et al., 2008). ES cell derived hepatocytes implanted in a bio-artificial liver devices have also been shown to partially reverse fulminant liver failure and 90% hepatectomy in mice (Cho et al., 2008; Soto-Gutierrez et al., 2006).

While these results provide a promising proof of principle there are still limitations. In addition to poor engraftment, the hepatic-like cells produced still have characteristics of fetal hepatocytes such as Afp expression (Agarwal et al., 2008; Cai et al., 2007; Gouon-Evans et al., 2006), suggesting that the cells are not fully differentiated. It is likely that continued investigations into normal liver development would enhance our ability to differentiate ES cells into therapeutically useful hepatic tissue in vitro.

10. Conclusions

In the last ten years researchers have uncovered many of the genes regulating hepatogenesis. One of the emerging themes is that many of the same signaling pathways and transcription factors are used reiteratively, and have different functions at different times in development. A major challenge now is to understand how all these genes and pathways interact in a precise temporal sequence to direct a naïve endoderm cell into a functional hepatocyte. In addition there are still gaps in our knowledge of both early foregut patterning and later aspects of hepatic maturation. The recent rise of alternative model organisms such as genetic screens in fish and functional assays in Xenopus are helping to accelerate our understanding of early hepatogenesis (Cheng et al., 2006; Ober et al., 2006; Sadler et al., 2005). Finally the use of hepatic progenitor cell cultures as well as in vitro liver development from ES cells will be valuable models for studying hepatic differentiation.


1. Acknowledgement

I apologize to authors whose work I could not describe due to space constraints. I am grateful to Gail Deutsch, Jay Kormish, Chris Mayhew, Scott Rankin, Jason Spence and Jim Wells for comments on the manuscript and for providing images for the figures. Liver research in the Zorn lab is supported by the NIH grant DK070858.

References

Ader, T. Norel, R. Levoci, L. Rogler, L.E. (2006). Transcriptional profiling implicates TGFbeta/BMP and Notch signaling pathways in ductular differentiation of fetal murine hepatoblasts. Mech Dev 123, 177–194.

Afouda, B.A. Ciau-Uitz, A. Patient, R. (2005). GATA4, 5 and 6 mediate TGFbeta maintenance of endodermal gene expression in Xenopus embryos. Development 132, 763–774.

Agarwal, S. Holton, K.L. Lanza, R. (2008). Efficient Differentiation of Functional Hepatocytes from Human Embryonic Stem Cells. Stem Cells.

Apte, U. Thompson, M.D. Cui, S. Liu, B. Cieply, B. Monga, S.P. (2008). Wnt/beta-catenin signaling mediates oval cell response in rodents. Hepatology 47, 288–295.

Apte, U. Zeng, G. Muller, P. Tan, X. Micsenyi, A. Cieply, B. Dai, C. Liu, Y. Kaestner, K.H. Monga, S.P. (2006). Activation of Wnt/beta-catenin pathway during hepatocyte growth factor-induced hepatomegaly in mice. Hepatology 44, 992–1002.

Baharvand, H. Hashemi, S.M. Shahsavani, M. (2007). Differentiation of human embryonic stem cells into functional hepatocyte-like cells in a serum-free adherent culture condition. Differentiation.

Battle, M.A. Konopka, G. Parviz, F. Gaggl, A.L. Yang, C. Sladek, F.M. Duncan, S.A. (2006). Hepatocyte nuclear factor 4alpha orchestrates expression of cell adhesion proteins during the epithelial transformation of the developing liver. Proc Natl Acad Sci USA 103, 8419–8424.

Beg, A.A. Sha, W.C. Bronson, R.T. Ghosh, S. Baltimore, D. (1995). Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature 376, 167–170.

Berg, T. Rountree, C.B. Lee, L. Estrada, J. Sala, F.G. Choe, A. Veltmaat, J.M. De Langhe, S. Lee, R. Tsukamoto, H. (2007). Fibroblast growth factor 10 is critical for liver growth during embryogenesis and controls hepatoblast survival via beta-catenin activation. Hepatology 46, 1187–1197.

Birchmeier, C. Birchmeier, W. Gherardi, E. Vande Woude, G.F. (2003). Met, metastasis, motility and more. Nat Rev Mol Cell Biol 4, 915–925.

Bird, T.G. Lorenzini, S. Forbes, S.J. (2008). Activation of stem cells in hepatic diseases. Cell Tissue Res 331, 283–300.

Bladt, F. Riethmacher, D. Isenmann, S. Aguzzi, A. Birchmeier, C. (1995). Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud. Nature 376, 768–771.

Block, G.D. Locker, J. Bowen, W.C. Petersen, B.E. Katyal, S. Strom, S.C. Riley, T. Howard, T.A. Michalopoulos, G.K. (1996). Population expansion, clonal growth, and specific differentiation patterns in primary cultures of hepatocytes induced by HGF/SF, EGF and TGF alpha in a chemically defined (HGM) medium. J Cell Biol 132, 1133–1149.

Bogue, C.W. Ganea, G.R. Sturm, E. Ianucci, R. Jacobs, H.C. (2000). Hex expression suggests a role in the development and function of organs derived from foregut endoderm. Dev Dyn 219, 84–89.

Bonnard, M. Mirtsos, C. Suzuki, S. Graham, K. Huang, J. Ng, M. Itie, A. Wakeham, A. Shahinian, A. Henzel, W.J. (2000). Deficiency of T2K leads to apoptotic liver degeneration and impaired NF-kappaB-dependent gene transcription. Embo J 19, 4976–4985.

Bort, R. Martinez-Barbera, J.P. Beddington, R.S. Zaret, K.S. (2004). Hex homeobox gene-dependent tissue positioning is required for organogenesis of the ventral pancreas. Development 131, 797–806.

Bort, R. Signore, M. Tremblay, K. Barbera, J.P. Zaret, K.S. (2006). Hex homeobox gene controls the transition of the endoderm to a pseudostratified, cell emergent epithelium for liver bud development. Dev Biol 290, 44–56.

Bossard, P. Zaret, K.S. (1998). GATA transcription factors as potentiators of gut endoderm differentiation. Development 125, 4909–4917.

Bossard, P. Zaret, K.S. (2000). Repressive and restrictive mesodermal interactions with gut endoderm: possible relation to Meckel's Diverticulum. Development 127, 4915–4923.

Burke, Z. Oliver, G. (2002). Prox1 is an early specific marker for the developing liver and pancreas in the mammalian foregut endoderm. Mech Dev 118, 147–155.

Cai, J. Zhao, Y. Liu, Y. Ye, F. Song, Z. Qin, H. Meng, S. Chen, Y. Zhou, R. Song, X. (2007). Directed differentiation of human embryonic stem cells into functional hepatic cells. Hepatology 45, 1229–1239.

Calmont, A. Wandzioch, E. Tremblay, K.D. Minowada, G. Kaestner, K.H. Martin, G.R. Zaret, K.S. (2006). An FGF response pathway that mediates hepatic gene induction in embryonic endoderm cells. Dev Cell 11, 339–348.

Chalmers, A.D. Slack, J.M. (2000). The Xenopus tadpole gut: fate maps and morphogenetic movements. Development 127, 381–392.

Chen, L. Kwong, M. Lu, R. Ginzinger, D. Lee, C. Leung, L. Chan, J.Y. (2003). Nrf1 is critical for redox balance and survival of liver cells during development. Mol Cell Biol 23, 4673–4686.

Chen, Y. Jurgens, K. Hollemann, T. Claussen, M. Ramadori, G. Pieler, T. (2003). Cell-autonomous and signal-dependent expression of liver and intestine marker genes in pluripotent precursor cells from Xenopus embryos. Mech Dev 120, 277–288.

Chen, Y. Pan, F.C. Brandes, N. Afelik, S. Solter, M. Pieler, T. (2004). Retinoic acid signaling is essential for pancreas development and promotes endocrine at the expense of exocrine cell differentiation in Xenopus. Dev Biol 271, 144–160.

Chen, Y. Soto-Gutierrez, A. Navarro-Alvarez, N. Rivas-Carrillo, J.D. Yamatsuji, T. Shirakawa, Y. Tanaka, N. Basma, H. Fox, I.J. Kobayashi, N. (2006). Instant hepatic differentiation of human embryonic stem cells using activin A and a deleted variant of HGF. Cell Transplant 15, 865–871.

Cheng, W. Guo, L. Zhang, Z. Soo, H.M. Wen, C. Wu, W. Peng, J. (2006). HNF factors form a network to regulate liver-enriched genes in zebrafish. Dev Biol 294, 482–496.

Cho, C.H. Parashurama, N. Park, E.Y. Suganuma, K. Nahmias, Y. Park, J. Tilles, A.W. Berthiaume, F. Yarmush, M.L. (2008). Homogeneous differentiation of hepatocyte-like cells from embryonic stem cells: applications for the treatment of liver failure. Faseb J 22, 898–909.

Clotman, F. Jacquemin, P. Plumb-Rudewiez, N. Pierreux, C.E. Van der Smissen, P. Dietz, H.C. Courtoy, P.J. Rousseau, G.G. Lemaigre, F.P. (2005). Control of liver cell fate decision by a gradient of TGF beta signaling modulated by Onecut transcription factors. Genes Dev 19, 1849–1854.

Clotman, F. Lannoy, V.J. Reber, M. Cereghini, S. Cassiman, D. Jacquemin, P. Roskams, T. Rousseau, G.G. Lemaigre, F.P. (2002). The onecut transcription factor HNF6 is required for normal development of the biliary tract. Development 129, 1819–1828.

Clotman, F. Lemaigre, F. P. (2006). Control of hepatic differentiation by activin/TGFbeta signaling. Cell Cycle 5, 168–171.

Coffinier, C. Gresh, L. Fiette, L. Tronche, F. Schutz, G. Babinet, C. Pontoglio, M. Yaniv, M. Barra, J. (2002). Bile system morphogenesis defects and liver dysfunction upon targeted deletion of HNF1beta. Development 129, 1829–1838.

D’Amour, K.A. Agulnick, A.D. Eliazer, S. Kelly, O.G. Kroon, E. Baetge, E.E. (2005). Efficient differentiation of human embryonic stem cells to definitive endoderm. Nat Biotechnol 23, 1534–1541.

Dan, Y.Y. Yeoh, G.C. (2008). Liver stem cells: a scientific and clinical perspective. J Gastroenterol Hepatol 23, 687–698.

Decaens, T. Godard, C. de Reynies, A. Rickman, D.S. Tronche, F. Couty, J.P. Perret, C. Colnot, S. (2008). Stabilization of beta-catenin affects mouse embryonic liver growth and hepatoblast fate. Hepatology 47, 247–258.

Defrances, M.C. Wolf, H.K. Michalopoulos, G.K. Zarnegar, R. (1992). The presence of hepatocyte growth factor in the developing rat. Development 116, 387–395.

Desmet, V.J. (2005). Cystic diseases of the liver. From embryology to malformations. Gastroenterol Clin Biol 29, 858–860.

Dessimoz, J. Opoka, R. Kordich, J.J. Grapin-Botton, A. Wells, J.M. (2006). FGF signaling is necessary for establishing gut tube domains along the anterior-posterior axis in vivo. Mech Dev 123, 42–55.

Deutsch, G. Jung, J. Zheng, M. Lora, J. Zaret, K.S. (2001). A bipotential precursor population for pancreas and liver within the embryonic endoderm. Development 128, 871–881.

Doi, T.S. Marino, M.W. Takahashi, T. Yoshida, T. Sakakura, T. Old, L. J. Obata, Y. (1999). Absence of tumor necrosis factor rescues RelA-deficient mice from embryonic lethality. Proc Natl Acad Sci USA 96, 2994–2999.

Dong, P.D. Munson, C.A. Norton, W. Crosnier, C. Pan, X. Gong, Z. Neumann, C.J. Stainier, D.Y. (2007). Fgf10 regulates hepatopancreatic ductal system patterning and differentiation. Nat Genet 39, 397–402.

Dufort, D. Schwartz, L. Harpal, K. Rossant, J. (1998). The transcription factor HNF3beta is required in visceral endoderm for normal primitive streak morphogenesis. Development 125, 3015–3025.

Duncan, S.A. (2005). Generation of embryos directly from embryonic stem cells by tetraploid embryo complementation reveals a role for GATA factors in organogenesis. Biochem Soc Trans 33, 1534–1536.

Eferl, R. Sibilia, M. Hilberg, F. Fuchsbichler, A. Kufferath, I. Guertl, B. Zenz, R. Wagner, E.F. Zatloukal, K. (1999). Functions of c-Jun in liver and heart development. J Cell Biol 145, 1049–1061.

Fassler, R. Meyer, M. (1995). Consequences of lack of beta 1 integrin gene expression in mice. Genes Dev 9, 1896–1908.

Fausto, N. (2004). Liver regeneration and repair: hepatocytes, progenitor cells, and stem cells. Hepatology 39, 1477–1487.

Fausto, N. Campbell, J.S. Riehle, K.J. (2006). Liver regeneration. Hepatology 43, S45–53.

Fougere-Deschatrette, C. Imaizumi-Scherrer, T. Strick-Marchand, H. Morosan, S. Charneau, P. Kremsdorf, D. Faust, D.M. Weiss, M.C. (2006). Plasticity of hepatic cell differentiation: bipotential adult mouse liver clonal cell lines competent to differentiate in vitro and in vivo. Stem Cells 24, 2098–2109.

Fruman, D.A. Mauvais-Jarvis, F. Pollard, D.A. Yballe, C.M. Brazil, D. Bronson, R.T. Kahn, C.R. Cantley, L.C. (2000). Hypoglycaemia, liver necrosis and perinatal death in mice lacking all isoforms of phosphoinositide 3-kinase p85 alpha. Nat Genet 26, 379–382.

Fukuda-Taira, S. (1981). Hepatic induction in the avian embryo: Specificity of reactive endoderm and inductive mesoderm. J Embryol exp Morph 63, 111–125.

Ganiatsas, S. Kwee, L. Fujiwara, Y. Perkins, A. Ikeda, T. Labow, M. A. Zon, L. I. (1998). SEK1 deficiency reveals mitogen-activated protein kinase cascade crossregulation and leads to abnormal hepatogenesis. Proc Natl Acad Sci USA 95, 6881–6886.

Giroux, S. Charron, J. (1998). Defective development of the embryonic liver in N-myc-deficient mice. Dev Biol 195, 16–28.

Gouon-Evans, V. Boussemart, L. Gadue, P. Nierhoff, D. Koehler, C.I. Kubo, A. Shafritz, D.A. Keller, G. (2006). BMP-4 is required for hepatic specification of mouse embryonic stem cell-derived definitive endoderm. Nat Biotechnol 24, 1402–1411.

Grapin-Botton, A. (2005). Antero-posterior patterning of the vertebrate digestive tract: 40 years after Nicole Le Douarin's PhD thesis. Int J Dev Biol 49, 335–347.

Gualdi, R. Bossard, P. Zheng, M. Hamada, Y. Coleman, J.R. Zaret, K.S. (1996). Hepatic specification of the gut endoderm in vitro: cell signaling and transcriptional control. Genes Dev 10, 1670–1682.

Gunes, C. Heuchel, R. Georgiev, O. Muller, K.H. Lichtlen, P. Bluthmann, H. Marino, S. Aguzzi, A. Schaffner, W. (1998). Embryonic lethality and liver degeneration in mice lacking the metal-responsive transcriptional activator MTF-1. Embo J 17, 2846–2854.

Hay, D.C. Zhao, D. Fletcher, J. Hewitt, Z.A. McLean, D. Urruticoechea-Uriguen, A. Black, J.R. Elcombe, C. Ross, J.A. Wolf, R. Cui, W. (2008). Efficient Differentiation of Hepatocytes from Human Embryonic Stem Cells Exhibiting Markers Recapitulating Liver Development In Vivo. Stem Cells.

Hentsch, B. Lyons, I. Li, R. Hartley, L. Lints, T.J. Adams, J. M. Harvey, R.P. (1996). Hlx homeo box gene is essential for an inductive tissue interaction that drives expansion of embryonic liver and gut. Genes Dev 10, 70–79.

Heo, J. Factor, V.M. Uren, T. Takahama, Y. Lee, J.S. Major, M. Feinstone, S.M. Thorgeirsson, S.S. (2006). Hepatic precursors derived from murine embryonic stem cells contribute to regeneration of injured liver. Hepatology 44, 1478–1486.

Hilberg, F. Aguzzi, A. Howells, N. Wagner, E.F. (1993). c-jun is essential for normal mouse development and hepatogenesis. Nature 365, 179–181.

Holtzinger, A. Evans, T. (2005). Gata4 regulates the formation of multiple organs. Development 132, 4005–4014.

Horb, M.E. Slack, J.M. (2001). Endoderm specification and differentiation in Xenopus embryos. Dev Biol 236, 330–343.

Horslen, S.P. Fox, I.J. (2004). Hepatocyte transplantation. Transplantation 77, 1481–1486.

Houssaint, E. (1980). Differentiation of the mouse hepatic primordium. I. An analysis of tissue interactions in hepatocyte differentiation. Cell Differ 9, 269–279.

Hu, M. Kurobe, M. Jeong, Y.J. Fuerer, C. Ghole, S. Nusse, R. Sylvester, K.G. (2007). Wnt/beta-catenin signaling in murine hepatic transit amplifying progenitor cells. Gastroenterology 133, 1579–1591.

Hunter, M.P. Wilson, C.M. Jiang, X. Cong, R. Vasavada, H. Kaestner, K.H. Bogue, C.W. (2007). The homeobox gene Hhex is essential for proper hepatoblast differentiation and bile duct morphogenesis. Dev Biol 308, 355–367.

Hussain, S.Z. Sneddon, T. Tan, X. Micsenyi, A. Michalopoulos, G.K. Monga, S.P. (2004). Wnt impacts growth and differentiation in ex vivo liver development. Exp Cell Res 292, 157–169.

Iida, I. Johkura, K. Teng, R. Kubota, S. Cui, L. Zhao, X. Ogiwara, N. Okouchi, Y. Asanuma, K. Nakayama, J. Sasaki, K. (2003). Immunohistochemical localization of hepatocyte growth factor activator (HGFA) in developing mouse liver tissues. Heterogeneous distribution of HGFA protein. J Histochem Cytochem 51, 1139–1149.

Ijpenberg, A. Perez-Pomares, J.M. Guadix, J.A. Carmona, R. Portillo-Sanchez, V. Macias, D. Hohenstein, P. Miles, C.M. Hastie, N.D. Munoz-Chapuli, R. (2007). Wt1 and retinoic acid signaling are essential for stellate cell development and liver morphogenesis. Dev Biol 312, 157–170.

Imamura, M. Kojima, T. Lan, M. Son, S. Murata, M. Osanai, M. Chiba, H. Hirata, K. Sawada, N. (2007). Oncostatin M induces upregulation of claudin-2 in rodent hepatocytes coinciding with changes in morphology and function of tight junctions. Exp Cell Res 313, 1951–1962.

Ishikawa, K.S. Masui, T. Ishikawa, K. Shiojiri, N. (2001). Immunolocalization of hepatocyte growth factor and its receptor (c-Met) during mouse liver development. Histochem Cell Biol 116, 453–462.

Ito, Y. Matsui, T. Kamiya, A. Kinoshita, T. Miyajima, A. (2000). Retroviral gene transfer of signaling molecules into murine fetal hepatocytes defines distinct roles for the STAT3 and ras pathways during hepatic development. Hepatology 32, 1370–1376.

Jelnes, P. Santoni-Rugiu, E. Rasmussen, M. Friis, S.L. Nielsen, J. H. Tygstrup, N. Bisgaard, H.C. (2007). Remarkable heterogeneity displayed by oval cells in rat and mouse models of stem cell-mediated liver regeneration. Hepatology 45, 1462–1470.

Johnson, L. Greenbaum, D. Cichowski, K. Mercer, K. Murphy, E. Schmitt, E. Bronson, R.T. Umanoff, H. Edelmann, W. Kucherlapati, R. Jacks, T. (1997). K-ras is an essential gene in the mouse with partial functional overlap with N-ras. Genes Dev 11, 2468–2481.

Jung, J. Zheng, M. Goldfarb, M. Zaret, K.S. (1999). Initiation of mammalian liver development from endoderm by fibroblast growth factors. Science 284, 1998–2003.

Kalinichenko, V.V. Zhou, Y. Bhattacharyya, D. Kim, W. Shin, B. Bambal, K. Costa, R.H. (2002). Haploinsufficiency of the mouse Forkhead Box f1 gene causes defects in gall bladder development. J Biol Chem 277, 12369–12374.

Kamiya, A. Gonzalez, F.J. (2004). TNF-alpha regulates mouse fetal hepatic maturation induced by oncostatin M and extracellular matrices. Hepatology 40, 527–536.

Kamiya, A. Kinoshita, T. Ito, Y. Matsui, T. Morikawa, Y. Senba, E. Nakashima, K. Taga, T. Yoshida, K. Kishimoto, T. Miyajima, A. (1999). Fetal liver development requires a paracrine action of oncostatin M through the gp130 signal transducer. Embo J 18, 2127–2136.

Kamiya, A. Kinoshita, T. Miyajima, A. (2001). Oncostatin M and hepatocyte growth factor induce hepatic maturation via distinct signaling pathways. FEBS Lett 492, 90–94.

Kelley-Loughnane, N. Sabla, G.E. Ley-Ebert, C. Aronow, B.J. Bezerra, J.A. (2002). Independent and overlapping transcriptional activation during liver development and regeneration in mice. Hepatology 35, 525–534.

Keng, V.W. Yagi, H. Ikawa, M. Nagano, T. Myint, Z. Yamada, K. Tanaka, T. Sato, A. Muramatsu, I. Okabe, M. (2000). Homeobox gene Hex is essential for onset of mouse embryonic liver development and differentiation of the monocyte lineage. Biochem Biophys Res Commun 276, 1155–1161.

Kodama, Y. Hijikata, M. Kageyama, R. Shimotohno, K. Chiba, T. (2004). The role of notch signaling in the development of intrahepatic bile ducts. Gastroenterology 127, 1775–1786.

Konopka, G. Tekiela, J. Iverson, M. Wells, C. Duncan, S.A. (2007). Junctional adhesion molecule-A is critical for the formation of pseudocanaliculi and modulates E-cadherin expression in hepatic cells. J Biol Chem 282, 28137–28148.

Krupczak-Hollis, K. Wang, X. Kalinichenko, V.V. Gusarova, G. A. Wang, I.C. Dennewitz, M.B. Yoder, H.M. Kiyokawa, H. Kaestner, K. H. Costa, R.H. (2004). The mouse Forkhead Box m1 transcription factor is essential for hepatoblast mitosis and development of intrahepatic bile ducts and vessels during liver morphogenesis. Dev Biol 276, 74–88.

Kubo, A. Shinozaki, K. Shannon, J.M. Kouskoff, V. Kennedy, M. Woo, S. Fehling, H.J. Keller, G. (2004). Development of definitive endoderm from embryonic stem cells in culture. Development 131, 1651–1662.

Kumar, M. Jordan, N. Melton, D. Grapin-Botton, A. (2003). Signals from lateral plate mesoderm instruct endoderm toward a pancreatic fate. Dev Biol 259, 109–122.

Kyrmizi, I. Hatzis, P. Katrakili, N. Tronche, F. Gonzalez, F.J. Talianidis, I. (2006). Plasticity and expanding complexity of the hepatic transcription factor network during liver development. Genes Dev 20, 2293–2305.

Lavon, N. Benvenisty, N. (2005). Study of hepatocyte differentiation using embryonic stem cells. J Cell Biochem 96, 1193–1202.

Lawson, K.A. Pedersen, R.A. (1987). Cell fate, morphogenetic movement and population kinetics of embryonic endoderm at the time of germ layer formation in the mouse. Development 101, 627–652.

Le Douarin, N. (1964a). Induction de l’endoderme pre-hepatique par le mesoderme de l’aire cardiaque chez l’embryon de poulet. Journal of Embryology & Experimental Morphology 12, 651–664.

Le Douarin, N. (1964b). Isolement experimental du mesenchyme propre du foie et role morphogene de la composante mesodermique dans l’organogenese hepatique. Journal of Embryology & Experimental Morphology 12, 141–160.

Le Douarin, N.M. (1975). An experimental analysis of liver devleopment. Med Biol 53, 427–455.

Lee, C.S. Friedman, J.R. Fulmer, J.T. Kaestner, K.H. (2005). The initiation of liver development is dependent on Foxa transcription factors. Nature 435, 944–947.

Lee, C.S. Sund, N.J. Behr, R. Herrera, P.L. Kaestner, K.H. (2005). Foxa2 is required for the differentiation of pancreatic alpha-cells. Dev Biol 278, 484–495.

Lemaigre, F.P. (2003). Development of the biliary tract. Mech Dev 120, 81–87.

Li, J. Ning, G. Duncan, S.A. (2000). Mammalian hepatocyte differentiation requires the transcription factor HNF-4alpha. Genes Dev 14, 464–474.

Li, L. Krantz, I.D. Deng, Y. Genin, A. Banta, A.B. Collins, C.C. Qi, M. Trask, B.J. Kuo, W.L. Cochran, J. (1997). Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1. Nat Genet 16, 243–251.

Li, Q. Van Antwerp, D. Mercurio, F. Lee, K.F. Verma, I.M. (1999). Severe liver degeneration in mice lacking the IkappaB kinase 2 gene. Science 284, 321–325.

Lin, X. Jung, J. Kang, D. Xu, B. Zaret, K.S. Zoghbi, H. (2002). Prenylcysteine carboxylmethyltransferase is essential for the earliest stages of liver development in mice. Gastroenterology 123, 345–351.

Loomes, K.M. Russo, P. Ryan, M. Nelson, A. Underkoffler, L. Glover, C. Fu, H. Gridley, T. Kaestner, K.H. Oakey, R.J. (2007). Bile duct proliferation in liver-specific Jag1 conditional knockout mice: effects of gene dosage. Hepatology 45, 323–330.

Lozier, J. McCright, B. Gridley, T. (2008). Notch signaling regulates bile duct morphogenesis in mice. PLoS ONE 3, e1851.

Margagliotti, S. Clotman, F. Pierreux, C.E. Beaudry, J.B. Jacquemin, P. Rousseau, G.G. Lemaigre, F.P. (2007). The Onecut transcription factors HNF-6/OC-1 and OC-2 regulate early liver expansion by controlling hepatoblast migration. Dev Biol 311, 579–589.

Margagliotti, S. Clotman, F. Pierreux, C.E. Lemoine, P. Rousseau, G. G. Henriet, P. Lemaigre, F.P. (2008). Role of metalloproteinases at the onset of liver development. Dev Growth Differ 50, 331–338.

Martin, M. Gallego-Llamas, J. Ribes, V. Kedinger, M. Niederreither, K. Chambon, P. Dolle, P. Gradwohl, G. (2005). Dorsal pancreas agenesis in retinoic acid-deficient Raldh2 mutant mice. Dev Biol 284, 399–411.

Martinez Barbera, J. P. Clements, M. Thomas, P. Rodriguez, T. Meloy, D. Kioussis, D. Beddington, R.S. (2000). The homeobox gene Hex is required in definitive endodermal tissues for normal forebrain, liver and thyroid formation. Development 127, 2433–2445.

Matsui, T. Kinoshita, T. Hirano, T. Yokota, T. Miyajima, A. (2002). STAT3 down-regulates the expression of cyclin D during liver development. J Biol Chem 277, 36167–36173.

Matsui, T. Kinoshita, T. Morikawa, Y. Tohya, K. Katsuki, M. Ito, Y. Kamiya, A. Miyajima, A. (2002). K-Ras mediates cytokine-induced formation of E-cadherin-based adherens junctions during liver development. Embo J 21, 1021–1030.

Matsumoto, K. Miki, R. Nakayama, M. Tatsumi, N. Yokouchi, Y. (2008). Wnt9a secreted from the walls of hepatic sinusoids is esseantial for morphogenesis, proliferations and glycogen accumulation of chick hepatic epithelium. Dev Biol. in press

Matsumoto, K. Yoshitomi, H. Rossant, J. Zaret, K.S. (2001). Liver organogenesis promoted by endothelial cells prior to vascular function. Science 294, 559–563.

Matthews, R.P. Lorent, K. Russo, P. Pack, M. (2004). The zebrafish onecut gene hnf-6 functions in an evolutionarily conserved genetic pathway that regulates vertebrate biliary development. Dev Biol 274, 245–259.

McCright, B. Lozier, J. Gridley, T. (2002). A mouse model of Alagille syndrome: Notch2 as a genetic modifier of Jag1 haploinsufficiency. Development 129, 1075–1082.

McKenzie, T. J. Lillegard, J. B. Nyberg, S. L. (2008). Artificial and bioartificial liver support. Semin Liver Dis 28, 210–217.

McLin, V.A. Rankin, S.A. Zorn, A.M. (2007). Repression of Wnt/{beta}-catenin signaling in the anterior endoderm is essential for liver and pancreas development. Development 134, 2207–2217.

Medico, E. Gentile, A. Lo Celso, C. Williams, T.A. Gambarotta, G. Trusolino, L. Comoglio, P.M. (2001). Osteopontin is an autocrine mediator of hepatocyte growth factor-induced invasive growth. Cancer Res 61, 5861–5868.

Medlock, E.S. Haar, J.L. (1983). The liver hemopoietic environment: I. Developing hepatocytes and their role in fetal hemopoiesis. Anat Rec 207, 31–41.

Michalopoulos, G.K. (2007). Liver regeneration. J Cell Physiol 213, 286–300.

Michalopoulos, G.K. Bowen, W. Nussler, A.K. Becich, M.J. Howard, T.A. (1993). Comparative analysis of mitogenic and morphogenic effects of HGF and EGF on rat and human hepatocytes maintained in collagen gels. J Cell Physiol 156, 443–452.

Michalopoulos, G.K. Bowen, W.C. Mule, K. Luo, J. (2003). HGF-, EGF-, and dexamethasone-induced gene expression patterns during formation of tissue in hepatic organoid cultures. Gene Expr 11, 55–75.

Micsenyi, A. Tan, X. Sneddon, T. Luo, J.H. Michalopoulos, G.K. Monga, S.P. (2004). Beta-catenin is temporally regulated during normal liver development. Gastroenterology 126, 1134–1146.

Mikula, M. Schreiber, M. Husak, Z. Kucerova, L. Ruth, J. Wieser, R. Zatloukal, K. Beug, H. Wagner, E.F. Baccarini, M. (2001). Embryonic lethality and fetal liver apoptosis in mice lacking the c-raf-1 gene. Embo J 20, 1952–1962.

Monga, S.P. Mars, W.M. Pediaditakis, P. Bell, A. Mule, K. Bowen, W. C. Wang, X. Zarnegar, R. Michalopoulos, G.K. (2002). Hepatocyte growth factor induces Wnt-independent nuclear translocation of beta-catenin after Met-beta-catenin dissociation in hepatocytes. Cancer Res 62, 2064–2071.

Monga, S.P. Monga, H.K. Tan, X. Mule, K. Pediaditakis, P. Michalopoulos, G.K. (2003). Beta-catenin antisense studies in embryonic liver cultures: role in proliferation, apoptosis, and lineage specification. Gastroenterology 124, 202–216.

Moore-Scott, B.A. Opoka, R. Lin, S.C. Kordich, J.J. Wells, J.M. (2007). Identification of molecular markers that are expressed in discrete anterior-posterior domains of the endoderm from the gastrula stage to mid-gestation. Dev Dyn 236, 1997–2003.

Motoyama, J. Kitajima, K. Kojima, M. Kondo, S. Takeuchi, T. (1997). Organogenesis of the liver, thymus and spleen is affected in jumonji mutant mice. Mech Dev 66, 27–37.

Moumen, A. Ieraci, A. Patane, S. Sole, C. Comella, J.X. Dono, R. Maina, F. (2007). Met signals hepatocyte survival by preventing Fas-triggered FLIP degradation in a PI3k-Akt-dependent manner. Hepatology 45, 1210–1217.

Nishina, H. Vaz, C. Billia, P. Nghiem, M. Sasaki, T. De la Pompa, J. L. Furlonger, K. Paige, C. Hui, C. Fischer, K.D. (1999). Defective liver formation and liver cell apoptosis in mice lacking the stress signaling kinase SEK1/MKK4. Development 126, 505–516.

Ober, E.A. Verkade, H. Field, H.A. Stainier, D.Y. (2006). Mesodermal Wnt2b signalling positively regulates liver specification. Nature 442, 688–691.

Ochsner, S.A. Strick-Marchand, H. Qiu, Q. Venable, S. Dean, A. Wilde, M. Weiss, M.C. Darlington, G.J. (2007). Transcriptional profiling of bipotential embryonic liver cells to identify liver progenitor cell surface markers. Stem Cells 25, 2476–2487.

Oda, T. Elkahloun, A.G. Pike, B.L. Okajima, K. Krantz, I.D. Genin, A. Piccoli, D.A. Meltzer, P.S. Spinner, N.B. Collins, F.S. Chandrasekharappa, S.C. (1997). Mutations in the human Jagged1 gene are responsible for Alagille syndrome. Nat Genet 16, 235–242.

Odom, D.T. Zizlsperger, N. Gordon, D.B. Bell, G.W. Rinaldi, N.J. Murray, H.L. Volkert, T.L. Schreiber, J. Rolfe, P.A. Gifford, D.K. (2004). Control of pancreas and liver gene expression by HNF transcription factors. Science 303, 1378–1381.

Oertel, M. Menthena, A. Chen, Y.Q. Teisner, B. Jensen, C.H. Shafritz, D.A. (2008). Purification of fetal liver stem/progenitor cells containing all the repopulation potential for normal adult rat liver. Gastroenterology 134, 823–832.

Oertel, M. Shafritz, D.A. (2008). Stem cells, cell transplantation and liver repopulation. Biochim Biophys Acta 1782, 61–74.

Okada, T.S. (1954). Experimental studies on the differentiation of the endodermal organs in Amphibia. II. Differentiating potencies of the presumptive endoderm in the presence of the mesodermal tissues. Mem Coll Univ Kyoto 21, 7–14.

Okada, T.S. (1960). Epithelio-mesenchymal relationships in the regional differentiation of the digestive tract in the amphibian embryo. Roux's Arch Dev Biol 152, 1–21.

Papoutsi, M. Dudas, J. Becker, J. Tripodi, M. Opitz, L. Ramadori, G. Wilting, J. (2007). Gene regulation by homeobox transcription factor Prox1 in murine hepatoblasts. Cell Tissue Res 330, 209–220.

Parviz, F. Matullo, C. Garrison, W.D. Savatski, L. Adamson, J.W. Ning, G. Kaestner, K.H. Rossi, J.M. Zaret, K.S. Duncan, S.A. (2003). Hepatocyte nuclear factor 4alpha controls the development of a hepatic epithelium and liver morphogenesis. Nat Genet 34, 292–296.

Pelton, R.W. Saxena, B. Jones, M. Moses, H.L. Gold, L.I. (1991). Immunohistochemical localization of TGF beta 1, TGF beta 2, and TGF beta 3 in the mouse embryo: expression patterns suggest multiple roles during embryonic development. J Cell Biol 115, 1091–1105.

Pontoglio, M. Barra, J. Hadchouel, M. Doyen, A. Kress, C. Bach, J.P. Babinet, C. Yaniv, M. (1996). Hepatocyte nuclear factor 1 inactivation results in hepatic dysfunction, phenylketonuria, and renal Fanconi syndrome. Cell 84, 575–585.

Porter, F.D. Drago, J. Xu, Y. Cheema, S.S. Wassif, C. Huang, S.P. Lee, E. Grinberg, A. Massalas, J.S. Bodine, D. (1997). Lhx2, a LIM homeobox gene, is required for eye, forebrain, and definitive erythrocyte development. Development 124, 2935–2944.

Qu, X. Lam, E. Doughman, Y.Q. Chen, Y. Chou, Y.T. Lam, M. Turakhia, M. Dunwoodie, S.L. Watanabe, M. Xu, B. (2007). Cited2, a coactivator of HNF4alpha, is essential for liver development. Embo J 26, 4445–4456.

Rastegar, M. Rousseau, G.G. Lemaigre, F.P. (2000). CCAAT/enhancer-binding protein-alpha is a component of the growth hormone-regulated network of liver transcription factors. Endocrinology 141, 1686–1692.

Reimold, A.M. Etkin, A. Clauss, I. Perkins, A. Friend, D.S. Zhang, J. Horton, H.F. Scott, A. Orkin, S.H. Byrne, M.C. (2000). An essential role in liver development for transcription factor XBP-1. Genes Dev 14, 152–157.

Roberts, D.J. Johnson, R.L. Burke, A.C. Nelson, C.E. Morgan, B.A. Tabin, C. (1995). Sonic hedgehog is an endodermal signal inducing Bmp-4 and Hox genes during induction and regionalization of the chick hindgut. Development 121, 3163–3174.

Rogler, L.E. (1997). Selective bipotential differentiation of mouse embryonic hepatoblasts in vitro. Am J Pathol 150, 591–602.

Rosenfeld, M.E. Prichard, L. Shiojiri, N. Fausto, N. (2000). Prevention of hepatic apoptosis and embryonic lethality in RelA/TNFR-1 double knockout mice. Am J Pathol 156, 997–1007.

Roskams, T. Desmet, V. (2008). Embryology of extra- and intrahepatic bile ducts, the ductal plate. Anat Rec (Hoboken) 291, 628–635.

Rossi, J.M. Dunn, N.R. Hogan, B.L. Zaret, K.S. (2001). Distinct mesodermal signals, including BMPs from the septum transversum mesenchyme, are required in combination for hepatogenesis from the endoderm. Genes Dev 15, 1998–2009.

Sachs, M. Brohmann, H. Zechner, D. Muller, T. Hulsken, J. Walther, I. Schaeper, U. Birchmeier, C. Birchmeier, W. (2000). Essential role of Gab1 for signaling by the c-Met receptor in vivo. J Cell Biol 150, 1375–1384.

Sadler, K.C. Amsterdam, A. Soroka, C. Boyer, J. Hopkins, N. (2005). A genetic screen in zebrafish identifies the mutants vps18, nf2 and foie gras as models of liver disease. Development 132, 3561–3572.

Satohisa, S. Chiba, H. Osanai, M. Ohno, S. Kojima, T. Saito, T. Sawada, N. (2005). Behavior of tight-junction, adherens-junction and cell polarity proteins during HNF-4alpha-induced epithelial polarization. Exp Cell Res 310, 66–78.

Schmelzer, E. Wauthier, E. Reid, L.M. (2006). The phenotypes of pluripotent human hepatic progenitors. Stem Cells 24, 1852–1858.

Schmidt, C. Bladt, F. Goedecke, S. Brinkmann, V. Zschiesche, W. Sharpe, M. Gherardi, E. Birchmeier, C. (1995). Scatter factor/hepatocyte growth factor is essential for liver development. Nature 373, 699–702.

Sekhon, S.S. Tan, X. Micsenyi, A. Bowen, W.C. Monga, S.P. (2004). Fibroblast growth factor enriches the embryonic liver cultures for hepatic progenitors. Am J Pathol 164, 2229–2240.

Sergi, C. Adam, S. Kahl, P. Otto, H.F. (2000). Study of the malformation of ductal plate of the liver in Meckel syndrome and review of other syndromes presenting with this anomaly. Pediatr Dev Pathol 3, 568–583.

Sergi, C. Kahl, P. Otto, H.F. (2000). Contribution of apoptosis and apoptosis-related proteins to the malformation of the primitive intrahepatic biliary system in Meckel syndrome. Am J Pathol 156, 1589–1598.

Serls, A.E. Doherty, S. Parvatiyar, P. Wells, J.M. Deutsch, G.H. (2005). Different thresholds of fibroblast growth factors pattern the ventral foregut into liver and lung. Development 132, 35–47.

Sharma, A.D. Cantz, T. Vogel, A. Schambach, A. Haridass, D. Iken, M. Bleidissel, M. Manns, M.P. Scholer, H.R. Ott, M. (2008). Murine embryonic stem cell-derived hepatic progenitor cells engraft in recipient livers with limited capacity of liver tissue formation. Cell Transplant 17, 313–323.

Shen, M.M. (2007). Nodal signaling: developmental roles and regulation. Development 134, 1023–1034.

Shin, D. Shin, C.H. Tucker, J. Ober, E.A. Rentzsch, F. Poss, K.D. Hammerschmidt, M. Mullins, M.C. Stainier, D.Y. (2007). Bmp and Fgf signaling are essential for liver specification in zebrafish. Development 134, 2041–2050.

Shiojiri, N. (1984). The origin of intrahepatic bile duct cells in the mouse. J Embryol Exp Morphol 79, 25–39.

Shiojiri, N. Sugiyama, Y. (2004). Immunolocalization of extracellular matrix components and integrins during mouse liver development. Hepatology 40, 346–355.

Shiojiri, N. Takeshita, K. Yamasaki, H. Iwata, T. (2004). Suppression of C/EBP alpha expression in biliary cell differentiation from hepatoblasts during mouse liver development. J Hepatol 41, 790–798.

Soriano, H.E. Bilyeu, T.A. Juan, T.S. Zhao, W. Darlington, G.J. (1995). DNA binding by C/EBP proteins correlates with hepatocyte proliferation. In Vitro Cell Dev Biol Anim 31, 703–709.

Sosa-Pineda, B. Wigle, J.T. Oliver, G. (2000). Hepatocyte migration during liver development requires Prox1. Nat Genet 25, 254–255.

Soto-Gutierrez, A. Kobayashi, N. Rivas-Carrillo, J.D. Navarro-Alvarez, N. Zhao, D. Okitsu, T. Noguchi, H. Basma, H. Tabata, Y. Chen, Y. (2006). Reversal of mouse hepatic failure using an implanted liver-assist device containing ES cell-derived hepatocytes. Nat Biotechnol 24, 1412–1419.

Soto-Gutierrez, A. Navarro-Alvarez, N. Zhao, D. Rivas-Carrillo, J.D. Lebkowski, J. Tanaka, N. Fox, I.J. Kobayashi, N. (2007). Differentiation of mouse embryonic stem cells to hepatocyte-like cells by co-culture with human liver nonparenchymal cell lines. Nat Protoc 2, 347–356.

Stafford, D. Hornbruch, A. Mueller, P.R. Prince, V.E. (2004). A conserved role for retinoid signaling in vertebrate pancreas development. Dev Genes Evol 214, 432–441.

Stenvers, K.L. Tursky, M.L. Harder, K.W. Kountouri, N. Amatayakul-Chantler, S. Grail, D. Small, C. Weinberg, R.A. Sizeland, A.M. Zhu, H.J. (2003). Heart and liver defects and reduced transforming growth factor beta2 sensitivity in transforming growth factor beta type III receptor-deficient embryos. Mol Cell Biol 23, 4371–4385.

Strick-Marchand, H. Morosan, S. Charneau, P. Kremsdorf, D. Weiss, M.C. (2004). Bipotential mouse embryonic liver stem cell lines contribute to liver regeneration and differentiate as bile ducts and hepatocytes. Proc Natl Acad Sci USA 101, 8360–8365.

Strick-Marchand, H. Weiss, M.C. (2002). Inducible differentiation and morphogenesis of bipotential liver cell lines from wild-type mouse embryos. Hepatology 36, 794–804.

Strick-Marchand, H. Weiss, M.C. (2003). Embryonic liver cells and permanent lines as models for hepatocyte and bile duct cell differentiation. Mech Dev 120, 89–98.

Suchy, F.J. (2003). Clinical problems with developmental anomalies of the biliary tract. Semin Gastrointest Dis 14, 156–164.

Suksaweang, S. Lin, C.M. Jiang, T.X. Hughes, M.W. Widelitz, R.B. Chuong, C.M. (2004). Morphogenesis of chicken liver: identification of localized growth zones and the role of beta-catenin/Wnt in size regulation. Dev Biol 266, 109–122.

Suzuki, A. Iwama, A. Miyashita, H. Nakauchi, H. Taniguchi, H. (2003). Role for growth factors and extracellular matrix in controlling differentiation of prospectively isolated hepatic stem cells. Development 130, 2513–2524.

Suzuki, A. Sekiya, S. Buscher, D. Izpisua Belmonte, J.C. Taniguchi, H. (2008). Tbx3 controls the fate of hepatic progenitor cells in liver development by suppressing p19ARF expression. Development 135, 1589–1595.

Suzuki, T. Kanai, Y. Hara, T. Sasaki, J. Sasaki, T. Kohara, M. Maehama, T. Taya, C. Shitara, H. Yonekawa, H. (2006). Crucial role of the small GTPase ARF6 in hepatic cord formation during liver development. Mol Cell Biol 26, 6149–6156.

Takata, N. (1960). The differentiation in vivo of the isolated endoderm under the influence of the mesoderm in Triturus Pyrrhogaster. Embryologica 5, 38–70.

Tan, X. Apte, U. Micsenyi, A. Kotsagrelos, E. Luo, J.H. Ranganathan, S. Monga, D.K. Bell, A. Michalopoulos, G.K. Monga, S.P. (2005). Epidermal growth factor receptor: a novel target of the Wnt/beta-catenin pathway in liver. Gastroenterology 129, 285–302.

Tan, X. Behari, J. Cieply, B. Michalopoulos, G.K. Monga, S.P. (2006). Conditional Deletion of beta-Catenin Reveals Its Role in Liver Growth and Regeneration. Gastroenterology 131, 1561–1572.

Tan, X. Yuan, Y. Zeng, G. Apte, U. Thompson, M.D. Cieply, B. Stolz, D.B. Michalopoulos, G.K. Kaestner, K.H. Monga, S.P. (2008). beta-Catenin deletion in hepatoblasts disrupts hepatic morphogenesis and survival during mouse development. Hepatology 47, 1667–1679.

Tang, Y. Katuri, V. Dillner, A. Mishra, B. Deng, C.X. Mishra, L. (2003). Disruption of transforming growth factor-beta signaling in ELF beta-spectrin-deficient mice. Science 299, 574–577.

Tanimizu, N. Miyajima, A. (2004). Notch signaling controls hepatoblast differentiation by altering the expression of liver-enriched transcription factors. J Cell Sci 117, 3165–3174.

Tatsumi, N. Miki, R. Katsu, K. Yokouchi, Y. (2007). Neurturin-GFRalpha2 signaling controls liver bud migration along the ductus venosus in the chick embryo. Dev Biol 307, 14–28.

Teratani, T. Yamamoto, H. Aoyagi, K. Sasaki, H. Asari, A. Quinn, G. Terada, M. Ochiya, T. (2005). Direct hepatic fate specification from mouse embryonic stem cells. Hepatology 41, 836–846.

Thomas, P.Q. Brown, A. Beddington, R.S. (1998). Hex: a homeobox gene revealing peri-implantation asymmetry in the mouse embryo and an early transient marker of endothelial cell precursors. Development 125, 85–94.

Tiso, N. Filippi, A. Pauls, S. Bortolussi, M. Argenton, F. (2002). BMP signalling regulates anteroposterior endoderm patterning in zebrafish. Mech Dev 118, 29–37.

Tomizawa, M. Garfield, S. Factor, V. Xanthopoulos, K. G. (1998). Hepatocytes deficient in CCAAT/enhancer binding protein alpha (C/EBP alpha) exhibit both hepatocyte and biliary epithelial cell character. Biochem Biophys Res Commun 249, 1–5.

Tremblay, K.D. Zaret, K.S. (2005). Distinct populations of endoderm cells converge to generate the embryonic liver bud and ventral foregut tissues. Dev Biol 280, 87–99.

Wandzioch, E. Kolterud, A. Jacobsson, M. Friedman, S.L. Carlsson, L. (2004). Lhx2-/- mice develop liver fibrosis. Proc Natl Acad Sci USA 101, 16549–16554.

Wang, N.D. Finegold, M.J. Bradley, A. Ou, C.N. Abdelsayed, S.V. Wilde, M.D. Taylor, L.R. Wilson, D.R. Darlington, G.J. (1995). Impaired energy homeostasis in C/EBP alpha knockout mice. Science 269, 1108–1112.

Wang, Z. Dolle, P. Cardoso, W.V. Niederreither, K. (2006). Retinoic acid regulates morphogenesis and patterning of posterior foregut derivatives. Dev Biol 297, 433–445.

Watanabe, T. Nakagawa, K. Ohata, S. Kitagawa, D. Nishitai, G. Seo, J. Tanemura, S. Shimizu, N. Kishimoto, H. Wada, T. (2002). SEK1/MKK4-mediated SAPK/JNK signaling participates in embryonic hepatoblast proliferation via a pathway different from NF-kappaB-induced anti-apoptosis. Dev Biol 250, 332–347.

Watt, A.J. Garrison, W.D. Duncan, S.A. (2003). HNF4: a central regulator of hepatocyte differentiation and function. Hepatology 37, 1249–1253.

Watt, A.J. Zhao, R. Li, J. Duncan, S.A. (2007). Development of the mammalian liver and ventral pancreas is dependent on GATA4. BMC Dev Biol 7, 37.

Weinstein, M. Monga, S.P. Liu, Y. Brodie, S.G. Tang, Y. Li, C. Mishra, L. Deng, C.X. (2001). Smad proteins and hepatocyte growth factor control parallel regulatory pathways that converge on beta1-integrin to promote normal liver development. Mol Cell Biol 21, 5122–5131.

Wells, J.M. Melton, D.A. (2000). Early mouse endoderm is patterned by soluble factors from adjacent germ layers. Development 127, 1563–1572.

Yamasaki, H. Sada, A. Iwata, T. Niwa, T. Tomizawa, M. Xanthopoulos, K.G. Koike, T. Shiojiri, N. (2006). Suppression of C/EBPalpha expression in periportal hepatoblasts may stimulate biliary cell differentiation through increased Hnf6 and Hnf1b expression. Development 133, 4233–4243.

Yanai, M. Tatsumi, N. Hasunuma, N. Katsu, K. Endo, F. Yokouchi, Y. (2008). FGF signaling segregates biliary cell-lineage from chick hepatoblasts cooperatively with BMP4 and ECM components in vitro. Dev Dyn 237, 1268–1283.

Yasunaga, M. Tada, S. Torikai-Nishikawa, S. Nakano, Y. Okada, M. Jakt, L.M. Nishikawa, S. Chiba, T. Era, T. (2005). Induction and monitoring of definitive and visceral endoderm differentiation of mouse ES cells. Nat Biotechnol 23, 1542–1550.

Yovchev, M.I. Grozdanov, P.N. Zhou, H. Racherla, H. Guha, C. Dabeva, M.D. (2008). Identification of adult hepatic progenitor cells capable of repopulating injured rat liver. Hepatology 47, 636–647.

Yuan, Z.R. Kobayashi, N. Kohsaka, T. (2006). Human Jagged 1 mutants cause liver defect in Alagille syndrome by overexpression of hepatocyte growth factor. J Mol Biol 356, 559–568.

Zaret, K.S. (2008). Genetic programming of liver and pancreas progenitors: lessons for stem-cell differentiation. Nat Rev Genet.

Zeng, G. Awan, F. Otruba, W. Muller, P. Apte, U. Tan, X. Gandhi, C. Demetris, A.J. Monga, S.P. (2007). Wnt’er in liver: expression of Wnt and frizzled genes in mouse. Hepatology 45, 195–204.

Zhang, W. Yatskievych, T.A. Baker, R.K. Antin, P.B. (2004). Regulation of Hex gene expression and initial stages of avian hepatogenesis by Bmp and Fgf signaling. Dev Biol 268, 312–326.

Zhao, R. Duncan, S.A. (2005). Embryonic development of the liver. Hepatology 41, 956–967.

Zhao, R. Watt, A.J. Battle, M.A. Li, J. Bondow, B.J. Duncan, S.A. (2008). Loss of both GATA4 and GATA6 blocks cardiac myocyte differentiation and results in acardia in mice. Dev Biol 317, 614–619.

Zhao, R. Watt, A.J. Li, J. Luebke-Wheeler, J. Morrisey, E.E. Duncan, S.A. (2005). GATA6 is essential for embryonic development of the liver but dispensable for early heart formation. Mol Cell Biol 25, 2622–2631.

Zorn, A.M. Wells, J.M. (2007). Molecular basis of vertebrate endoderm development. Int Rev Cytol 259, 49–111.

This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

To whom correspondence should be addressed. E-mail: Aaron.zorn@chmcc.org
*Edited by Alexander F. Schier. Last revised October 2, 2008. PublishedOctober 31, 2008. This chapter should be cited as: Zorn, A.M., Liver development (October 31, 2008), StemBook, ed. The Stem Cell Research Community, StemBook, doi/10.3824/stembook.1.25.1, http://www.stembook.org.